The Gene Frontier Expands: Twist Bioscience's Ambitious Leap The field of synthetic biology has been abuzz with excitement in recent years, driven by breakthroughs in gene editing and advanced sequencing technologies.
Twist Bioscience Corporation is now expanding its capabilities with an early access program for "Complex Genes," a new offering that enables researchers to synthesize longer and more complex DNA sequences than ever before.
This development addresses the growing challenge faced by researchers: their ability to accurately sequence and synthesize complex DNA molecules.